|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/415 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 31/4174 | (2006.01) | ||
| A61K 31/4174 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/006 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Patento numeris | 3562486 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17885750.4 |
| Europos patento paraiškos padavimo data | 2017-12-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/069030 |
| Data | 2017-12-29 |
| (87) | Numeris | WO 2018/126182 |
| Data | 2018-07-05 |
| (30) | Numeris | Data | Šalis |
| 201662441164 P | 2016-12-31 | US | |
| 201762471393 P | 2017-03-15 | US | |
| 201762542323 P | 2017-08-08 | US |
| (72) |
NANDABALAN, Krishnan , US
YOCCA, Frank , US
SHARMA, Sameer , US
|
| (73) |
BioXcel Therapeutics, Inc. ,
555 Long Wharf Drive, 5th Floor, New Haven, CT 06511,
US
|
| (54) | USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION |
| USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION |